tv White House COVID-19 Team Holds Briefing CSPAN April 27, 2021 12:20pm-12:52pm EDT
meant public health officials on the federal response to the pandemic, live coverage here on c-span. >> can we please begin the vaccination processed during the school year? >> i say this with the knowledge of having one, as well as a recent graduate now in his 20's, and the vaccine seems like the best way not to battle impulse to socialize. we are very supportive of states and their effort to improve access and make it even easier for students to get their shots. to do our part, we shared with governors that we will be ensuring that pharmacies in the federal pharmacy program do not have residency requirements in place, so that students who do return home can get their second dose in that home state.
most pharmacies administering shots will now offer anyone a second dose regardless of where they got their first, seems a good opportunity to remind you to get your second shot if it's your time and if you have it. we also discussed the vaccine allocation on the call. this week, nearly 30 million doses will go out, with the vast majority going to states, tribes, and territories. we reminded governors that the federal government stands ready to help states put shots into arms as quickly as possible and we continue to conduct one-on-one sessions with their teams each day throughout the week. i want to turn to the global situation and briefly address the recent covid-19 surged in india. first of all we stand with the
country of india during this very trying and tragic surge. over the weekend we shared that we are working to deploy resources and supplies including therapeutics and rapid testing kits, ppe and raw materials that are needed to manufacture vaccines in india and the cdc which has a long history of working with and in india on public health measures will be deploying the strike team to the country to support public health efforts there. we are committed to helping india through this difficult time. in addition, yesterday we announced that given the strong portfolio of approved, highly effective and safe vaccines in the united states, we are looking at the options to share the astrazeneca vaccines with other countries as they become available.
there should amount to around 60 million doses or so over the next few months. the astrazeneca vaccine is highly safe and effective and approved in many parts of the world and since it is not approved for use in the u.s. we do not need to use the astrazeneca vaccine here during the next few months. we have sufficient supply of vaccines from pfizer, moderna, and johnson & johnson to accommodate needs in the u.s.. in closing before i handed over to the doctor, vaccines are now broadly available, accessible, and located within five miles of 90% of americans. if you are 16 or above and have not been vaccinated, the scenes around the world should help convince you that now is the time and your risk from being unvaccinated is too high. please make an appointment today
, and with that i will turn it to dr. walensky. dr. walensky: thank you and good afternoon. let's begin with an overview of the day. yesterday the cdc reported over 34,000 600 cases of covid-19. our seven day average is just over 54,000 cases per day, and this represents a hopeful decline of about 21% from our prior seven day average. the seven day average of hospital admissions is just over 5100. a positive sign with a decrease of about 9% from the previous seven-day period. but seven-day average of daily deaths also declined to about 660 per day, a decrease of about 6%. each day more and more americans are rolling up their sleeves and getting vaccinated and likely contributing to these very positive trends.
we regularly share with you the benefits of vaccination, the efficacy in preventing infection and the decreases we have seen in hospitalizations and deaths. these are incredibly important benefits of vaccination and there are so many more. i know the quarantine and shut down throughout the pandemic have been exhausting. i know we all miss the things we used to do before the pandemic and that we all want to get back to doing those things we loved. today is another day we can take a step back to the normalcy of before. over the past year we have spent a lot of time telling americans what they cannot and should not do. today, i'm going to tell you some of the things you can do, if you are fully vaccinated. as a reminder, the cdc defines fully vaccinated as 14 days after your second dose of a pfizer or moderna vaccine, or 14 days after your single dose of
the johnson & johnson vaccine. today cdc is updating recommendations for a fully vaccinated people and providing guiding principles and sample activities to give people who are fully vaccinated away to assess their own risk for covid-19 and determine what situations are safe area if you are fully vaccinated things are much safer for you than those who are not yet fully vaccinated. this guidance will help you, your family, and your neighbors make decisions based on the latest science and allow you to safely get back to the things you love to do. optimistic that people will use this information to take personal responsibility to protect themselves and others and i hope will encourage people to get fully vaccinated. there are many situations where fully vaccinated people do not need to wear a mask. particularly if they are
outdoors, as shown by the graphic on the right. if you are fully vaccinated and want to attend a small outdoor gathering with people who are vaccinated and unvaccinated, or dine at an outdoor restaurant with friends from multiple households, the science shows, if you are vaccinated you can do so safely unmasked. on the cdc website we have examples of numerous outdoor activities that are safe to do without a mask if you are fully vaccinated. generally for vaccinated people outdoor activities without a mask are safe. we continue to recommend masking in crowded outdoor settings and venues such as packed stadiums and concerts where there is decreased ability to maintain physical distance and where many unvaccinated people may also be present. we will continue to recommend
this until widespread vaccination is achieved. let's talk about what you can do indoors. we have unvaccinated people and their risk on the left, nothing has changed. this is indicated and masking is required. we showed a remarkably decreased risk for vaccinated people on the right. given what we know about covid-19 vaccines and their efficacy it's also safe for those who are fully vaccinated to return to the activities they love doing inside while wearing a mask. the guiding principles we released today and the other examples compare the safety of several activities if you are vaccinated or not. the difference is clear. as we gather more data on the real efficacy of vaccines, we know that masked and fully vaccinated people can attend worship services inside, go to indoor restaurants or bars, and
even participate in an indoor exercise class. although these vaccines are extremely effective we know that the virus spreads very well indoors and entailed more people are vaccinated and while we still have more than 50,000 cases a day mask use indoors will provide extra protection. the examples today show that when you are fully vaccinated you can return to many activities safely, and most of them outdoors and unmasked, and begin to get back to normal. the more people who are vaccinated, the more steps we can take towards spending time with people we love, doing the things we love to enjoy. i hope this message is encouraging. it shows how powerful these vaccines are in the effort to in our efforts to end this pandemic and why we are asking everyone to roll up their sleeves and get vaccinated. the science is clear. the covid-19 vaccine has been
through many transparent, rigorous processes that continue to prove they are safe and effective. if you have not already, please get vaccinated. in some communities, you can find walk-up venues who have advanced appointments or where apartment are not even necessary. to see more details about what we released today, including the evidence and science behind these recommendations, and to learn more about the activities you can safely do when fully vaccinated, please go to cdc.gov. thank you. i will now turn things over to dr. fauci. dr. fauci: thank you very much, dr. walensky. i would like to take the next couple of minutes to talk about variants. we will look at evidence from clinical trials, and, when they are not available, from
laboratory studies as well as real-world experience to indicate the degree of protection against variants of interest or concern. here is a list very familiar to you of the number of the variants in place throughout the world and in the united states. so let's go quickly through them and make one or two comments to inform where we are. first, the b.1.1.7, the original u.k. variant, which has now been dominance in the united states. it is very clear this particular variant is covered very well by the mrna vaccines as well as why -- by the ashes in a car, novavax, and others, as shown by data from -- by the astrazeneca, novavax, and others, as shown is
that up the right. in the united kingdom, using other vaccines, similarly, you see the same situation. this is good news, since this is the dominant variant. next slide. the next slide is the one that is the most problematic, the south african variant, which is not dominant here but is in south africa and in other locations throughout the world. the data i have i presented at eight former conference. the j&j is 64% efficacious. the novavax, 60%. astrazeneca, not so good. of note, pfizer did a small study in which they looked at the effect in south africa and found that, as a matter of fact, it was 100% effective. the caveat here is it is still a very small study. but note the j&j, even though it was 64% effective in south
african study, there were virtually no deaths or hospitalizations. so although the efficacy went down for moderate disease, there was good protection against serious disease. then we have the p.1 -- the p.1, right now ravaging brazil. we know there is a variable protection and real-world effectiveness, namely things that were not done necessarily in the clinical trial. in brazil, it was 50% fictive after a single dose. they went on to a second dose, and that stayed at approximately 50%. this was under the condition with a 5% of the cases with p.1. similar results from chile. a little bit better with 67 percent effective disease 14 days after the second dose.
next slide. returning to the united states, the california variant, 429.427. here, we have mostly in vitro data. by "in vitro," we mean we take the antibodies induced in vaccine, in this case mrna, and determine their ability to neutralize the given variant in the test tube. as you can see, there is a slight to modest loss of about two- to threefold. this is not likely going to be relevant from a clinical standpoint, since there is a considerable cushion in the antibodies induced by this vaccine. next slide. then we have the 526, which was originally the new york, spreading in certain areas in the new york metropolitan area. here, too, we rely on in vitro data with a moderate loss of
three times to five times of neutralizing activity from the mrna. again, this is still within the christian you would see protected, since the antibodies induced by this -- within the christian -- the cushion you would see protected, since the antibodies induced -- now we have the troublesome india variant. the most recent data was looking at convalescent sera of covid-19 cases in people who received the vaccine using the covaxin. it was found to neutralize the 617 variant. so despite the real difficulty we are seeing in india, vaccination could be a very important antidote against this. so i will stop there with the final statement.
the one thing you can gather from everything i've said -- that it is very important to get vaccinated. as dr. walensky said, even when you're talking about variants, indoors, outdoors, get vaccinated, and you will certainly have a degree of protection. i will hand it back to you, andy. mr. slavitt: thank u.k. let's go to questions. >> thanks kate i know a lot of people have questions, so please keep it to one question. let's go to spectrum news. >> hi. thanks for taking my question. can you explain the guidance between the gardens change at this moment? is the understanding that there are enough americans sufficiently vaccinated to slow the spread that the likelihood of transmission is low outdoors, and what about the pockets of the country that have not reached national levels of vaccination? should the gardens be different for areas of lower vaccination rates? dr. walensky: there is
increasing data that suggests most of the transition is happening indoors rather than outdoors. less than 10% of documented transmission has occurred outdoors. and there is an overall 20 fold risk of transmission in the indoor setting compared to the out door setting. that coupled with the fact that we now have 37% of people over the age of 18 fully vaccinated and the fact that our case rates are now starting to come down, motivated our change of the items. this is the third time we have changed our guidance for fully vaccinated people, and as more people get vaccinated and as case rates continue to come down, we will come up with further updates. >> next question. >> cnn. >> thank you very much. my question -- given this new guidance, should states that have outdoor mask requirements change those to reflect this new guidance? is that your advice for those
states and governors? dr. walensky: what we are saying is states that have mask requirements outdoors, if people are vaccinated, we no longer feel the vaccinated people require masks outdoors. to the extent about those are consistent. i want to convey that outdoor large public venues, such as concerts, stadiums, and things like that, and a lot of that is the inability to distinction between vaccinated and unvaccinated. to say that, in those settings, when you have that density, we do worry about protecting the unvaccinated people. mr. slavitt: next question. >> the "atlanta journal-constitution." >> hi. i would like to go back to the question about the states that do not yet have the national range, that are below average. should there be different
guidance? i am calling from georgia. dr. walensky: i think the general guidance is to ensure people start getting vaccinated. we do know that if you are vaccinated, it is safe to be outdoors without a mask. the general guidance is the more and more people who get vaccinated, the more you will have more people who are safer without masks. so get vaccinated. if you are, it is safe to be outside without a mask. mr. slavitt: next question. >> nbc. >> hi, everyone. thank you so much. firstly, can you address if the risk of being outdoor solo, why do -- so low, why doesn't this apply to everyone? and while rates of vaccine hesitancy are dropping, you still have 4 in 10 americans saying maybe or they will not get the vaccine. how will you deal with that
hesitancy? are there any new strategies? mr. slavitt: dr. walensky? dr. walensky: we still believe that people in small gatherings and medium-sized gatherings, when you are unvaccinated, you are people at risk of severe disease, so we think in those settings masks should still occur. any activity is less risky when you have more ventilation and more space between people, more people wearing masks if they are unvaccinated. but again, i would go back to the primary principles of being outdoors in general and wearing masks outdoors until you have a vaccine. the second question? >> vaccine hesitancy, that vaccine hesitancy numbers are dropping, but it is still significant. i just had a conversation with someone yesterday who said they were not going to get the vaccine. i said why, and they said i still need more information for
how do you get to those people skeptical? dr. walensky: we are spending an extraordinary amount of outreach to those people. we wanted to first vaccinate everyone rolling up their sleeves immediately, then we had to do the work of meeting people where they are, understanding their reasons for not wanting to get vaccinated and explaining if it is about the science -- we believe and know that the science moved quickly. we have unrolled in 100,000 people in these trials, and the science stood on years and years of work before to be able to deliver these vaccines. dr. fauci has previously talked about that. if people are worried about side effects, we can deliver the data of the over 2 million vaccines delivered. we need to meet people where
they are and understand why they may be hesitant and give them the information to combat that hesitancy. mr. slavitt: dr. fauci, anything you want to add about the development of these vaccines over the last couple decades? dr. fauci: yeah, as dr. walensky said, we tried to go step-by-step of what is it about the situation that makes you hesitant? one of them is, in fact, the speed with which this has happened. we have been talking for a long time that vaccines usually take years to go from a recognition of the pathogen to getting vaccine into people's arms. we did it in 11 months. but as we have set often, that is a reflection of decades of scientific advances in two major areas. one, vaccine platform technology, which led to the years of work to perfect the mrna and the vector approach.
secondly, structure-based vaccine design that led to the precise, correct confirmation of the spike protein which proved to be so -- which translated into a highly efficacious vaccine. you are talking about decades of fundamental science. when people hear that, they realize this is not being rushed, that they are benefiting from the culmination of years of research. mr. slavitt: one thing we are cognizant of it is everyone has their own decision-making process. some people decide quickly, some take more time to decide. it is important we respect everybody's decision-making process. the person that you spoke about, our advice to them is talk to your doctor. talk to your pharmacist. talk to people you trust. talk to people who have taken the vaccine. and i think the picture that emerges is 130 million americans, hundreds more overseas -- significant
differences in their safety, and the risk to the viruses, particularly the variants, is more high. we will give the resources to do the homework, and we think that is what is responsible for moving more people in that direction. next question. >> "new york times." >> thank you. this is for dr. walensky. dr. walensky, you talk about small and medium-size gatherings, but you do not down fine -- define what they are. can you please define for people what a small in medium-size gathering is or say why you are not defining it, if there is some reason for that. separately, you talked a few weeks ago about feeling a sense of impending doom, and i wonder if you could reflect on that and talk a little bit more about how you feel right now, given the numbers. dr. walensky: thank you for that
question. what i will get back to is the basic concepts. if we define a small and medium-sized gathering, we also have to define the size of the space it is in, the ventilation that is occurring, the space between people. so i think we should get back to the general concept. small and medium-sized gatherings for people who are outside and vaccinated can safely be done without a mask. but we really do want people who are unvaccinated to limit the interaction with people and to go back to the basic principles of increased ventilation and increased spacing for any given size. several weeks ago when i had this feeling of impending doom and i articulated that, and i had case rates going up, vaccinations growing but not where we needed to be, and deaths continuing to climb. as i look at the curve now, it
is stabilizing, coming down. vaccinations have continued to grow in an extraordinary way. i think we really do need to get more and more people vaccinated. we need to combat the hesitancy to get people vaccinated, but as i've seen more vaccine getting into a people's arms, more more people willing to do so, confidence increases. and i match that with the cases starting to stabilize and plan so -- plateau and come down, as well as dr. fauci's slides with those countries a little ahead of us, that we should be in good shape. mr. slavitt: next question. >> ap. >> thanks for doing this. dr. walensky, i am wondering if you can clarify why are the people who are fully vaccinated, wearing masks, all of those
different scenarios, is it to protect others from in case -- or is it to model safe behavior for those unvaccinated in spaces around those. and if you do you -- and if you have any targets of people vaccinated to allow people to take their masks off at baseball stadiums or indoor dining or the like? dr. walensky: let me tackle the second question first. i think some of these targets have to be the interplay of the number of people vaccinated and the number of cases that we are seeing. it is that intersection that i feel will be important. one of the things we need to look at is the lack of uniformity across those vaccinated -- not every county or state is vaccinating up the same rate.
where we have low rates, we have to be careful and make sure people get vaccinated in all corners and all counties. with regards to why people who are vaccinated are wear masks indoors, what we really need to convey is we saw 50,000 cases a day. we believe vaccinated people are much safer when they are wearing those masks indoors, as indicated by the green on the red side of that graphic. and right now, it is hard to see who is vaccinated and where they are in their vaccinations, but it is really to protect others. mr. slavitt: next question. >> abc. >> i wanted to ask about a different topic. the reports that the pentagon is tracking 14 cases of myocarditis
among service members and families, people who were vaccinated through the military health care system. can you tell us any more about those cases and what cdc knows or what maybe dr. fauci can tell us about any potential relationship? mr. slavitt: maybe first will go to dr. walensky, if you have any familiarity? no? dr. walensky: i am aware of those reports. i do not necessarily want to comment on what the dod is doing in their own investigations. i will say we have delivered over 200 million doses of these vaccines, and after hearing about these reports, we again looked back at our vaccine safety data, and we have not seen that since those i've been reported. it is a different demographic than we normally see, and we will be working with the dod. we have not seen the signal in
the over 200 million doses we have given. mr. slavitt: so not enough data yet early. next question. >> we have time for one more question. yahoo! >> really quickly, can you walk us through the timeline of the aid being set, specifically for the ventilators and protective gear and oxygen, and secondly the vaccine doses, when you anticipate those will be sent out. mr. slavitt: we are beginning to move immediately. i cannot give you the exact timing on each of those pieces, but we are in constant contact with the indian government and indian health authorities. as i mentioned earlier, we have a cdc team headed to india to help coordinate this response. in terms of vaccines, we are in a position now that we are not
accepting to use the astrazeneca doses that we expect to come online. none of those doses are yet made available based on fda inspection. once that is done, soon as that happens, we will have 10 million doses available. those will be distributed globally. and then we excite another couple million. this is in addition to the many strategies that we have talked about for supplying the globe with additional vaccines and additional vaccination efforts through covax. and you may be aware that we are making sure that we are locating some of the raw materials necessary to create more vaccines in india, which i think will be an important help there. with that, i want to bring this to a close. thank you for all your questions. we will be doing this briefing again friday. [captions copyright national cable satellite corp. 2021] [captioning performed by the nation